David R. Liu - Net Worth and Insider Trading

David R. Liu Net Worth

The estimated net worth of David R. Liu is at least $88 Million dollars as of 2025-07-24. David R. Liu is the 10% Owner of Prime Medicine Inc and owns about 20,240,945 shares of Prime Medicine Inc (PRME) stock worth over $88 Million. Details can be seen in David R. Liu's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David R. Liu has not made any transactions after 2025-06-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of David R. Liu

To

David R. Liu Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David R. Liu owns 2 companies in total, including Editas Medicine Inc (EDIT) , and Prime Medicine Inc (PRME) .

Click here to see the complete history of David R. Liu’s form 4 insider trades.

Insider Ownership Summary of David R. Liu

Ticker Company Transaction Date Type of Owner
EDIT Editas Medicine Inc 2016-02-02 10 percent owner
PRME Prime Medicine Inc 2025-06-30 10 percent owner

David R. Liu Latest Holdings Summary

David R. Liu currently owns a total of 1 stock. David R. Liu owns 20,240,945 shares of Prime Medicine Inc (PRME) as of June 30, 2025, with a value of $88 Million.

Latest Holdings of David R. Liu

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PRME Prime Medicine Inc 2025-06-30 20,240,945 4.35 88,048,111

Holding Weightings of David R. Liu


David R. Liu Form 4 Trading Tracker

According to the SEC Form 4 filings, David R. Liu has made a total of 4 transactions in Prime Medicine Inc (PRME) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Prime Medicine Inc is the acquisition of 21,000 shares on June 30, 2025, which cost David R. Liu around $52,920.

Insider Trading History of David R. Liu

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

David R. Liu Trading Performance

GuruFocus tracks the stock performance after each of David R. Liu's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David R. Liu is %. GuruFocus also compares David R. Liu's trading performance to market benchmark return within the same time period. The performance of stocks bought by David R. Liu within 3 months outperforms times out of transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how David R. Liu's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of David R. Liu

Average Return

No transaction record over 1 Year.

Outperforming Transactions

No transaction record over 1 Year.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 209.61 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 205.41 LIMIT LIMIT LIMIT LIMIT LIMIT

David R. Liu Ownership Network

Ownership Network List of David R. Liu

No Data

Ownership Network Relation of David R. Liu

Insider Network Chart


David R. Liu Owned Company Details

What does Editas Medicine Inc do?

Who are the key executives at Editas Medicine Inc?

David R. Liu is the 10 percent owner of Editas Medicine Inc. Other key executives at Editas Medicine Inc include EVP & CHIEF SCIENTIFIC OFFICER Linda Burkly , director & CEO Gilmore Neil O'neill , and EVP & CHIEF FINANCIAL OFFICER Erick Lucera .

Editas Medicine Inc (EDIT) Insider Trades Summary

Over the past 18 months, David R. Liu made no insider transaction in Editas Medicine Inc (EDIT). Other recent insider transactions involving Editas Medicine Inc (EDIT) include a net sale of 125,012 shares made by Gilmore Neil O'neill , a net sale of 28,516 shares made by Baisong Mei , and a net sale of 15,503 shares made by Linda Burkly .

In summary, during the past 3 months, insiders sold 16,364 shares of Editas Medicine Inc (EDIT) in total and bought 0 shares, with a net sale of 16,364 shares. During the past 18 months, 195,923 shares of Editas Medicine Inc (EDIT) were sold and 45,000 shares were bought by its insiders, resulting in a net sale of 150,923 shares.

Editas Medicine Inc (EDIT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Editas Medicine Inc Insider Transactions

No Available Data

David R. Liu Mailing Address

Above is the net worth, insider trading, and ownership report for David R. Liu. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, David R. Liu's mailing address is: Cambridge Ma 02142.